The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Dual roles of Nrf2 in cancer
Open accessAbstract
In response to oxidative stress, the transcription factor NF-E2-related factor 2 (Nrf2) controls the fate of cells through transcriptional upregulation of antioxidant response element (ARE)-bearing genes, including those encoding endogenous antioxidants, phase II detoxifying enzymes, and transporters. Expression of the Nrf2-dependent proteins is critical for ameliorating or eliminating toxicants/carcinogens to maintain cellular redox homeostasis. As a result, activation of the Nrf2 pathway, by naturally-occurring compounds or synthetic chemicals at sub-toxic doses, confers protection against subsequent toxic/carcinogenic exposure. Thus, the use of dietary compounds or synthetic chemicals to boost the Nrf2-dependent adaptive response to counteract environmental insults has emerged to be a promising strategy for cancer prevention. Interestingly, recent emerging data has revealed the “dark” side of Nrf2. Nrf2 and its downstream genes are overexpressed in many cancer cell lines and human cancer tissues, giving cancer cells an advantage for survival and growth. Furthermore, Nrf2 is upregulated in resistant cancer cells and is thought to be responsible for acquired chemoresistance. Therefore, it may be necessary to inhibit the Nrf2 pathway during chemotherapy. This review is primarily focused on the role of Nrf2 in cancer, with emphasis on the recent findings indicating the cancer promoting function of Nrf2 and its role in acquired chemoresistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nuclear Import and Export Signals in Control of Nrf2
Jain, A. K., Bloom, D. A., & Jaiswal, A. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502083200 · Cited by 195
RetractedItoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 1×
“[5] Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al.”
BackgroundHayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,544
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
UBIQUITIN-DEPENDENT PROTEIN DEGRADATION
Hochstrasser, M. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.405 · Cited by 1,692
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · cited 2×
“Interestingly, we have shown that in cells cotransfected ith Keap1-C151, tBHQ or SF could no longer repress ubiquitinaion of Nrf2 and had no effect on the half-life of Nrf2 [4,40].”
BackgroundSelf-citationRushmore, T. H., Morton, M. R., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99004-6 · Cited by 1,464
Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., & Yamamoto, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16023 · Cited by 1,460
I NHIBITION OF C ARCINOGENESIS BY D IETARY P OLYPHENOLIC C OMPOUNDS
Yang, C. S., Landau, J. M., Huang, M.-T., & Newmark, H. L. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.381 · Cited by 1,260
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S.-C., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,254
Self-citationMcMahon, M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300931200 · Cited by 1,141 · cited 1×
“[47] McMahon M, Itoh K, Yamamoto M, Hayes JD.”
BackgroundRamos-Gomez, M., Kwak, M.-K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., & Kensler, T. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051618798 · Cited by 1,102
Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway
Zhang, D. D. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600971974 · Cited by 1,086
Self-citationDysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030420 · Cited by 1,060
Venugopal, R., & Jaiswal, A. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14960 · Cited by 1,040
BALOGUN, E., HOQUE, M., GONG, P., KILLEEN, E., GREEN, C. J., FORESTI, R., ALAM, J., & MOTTERLINI, R. (2003) · Biochemical Journal · doi:10.1042/bj20021619 · Cited by 1,036
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice
Rangasamy, T., Cho, C. Y., Thimmulappa, R. K., Zhen, L., Srisuma, S. S., Kensler, T. W., Yamamoto, M., Petrache, I., Tuder, R. M., & Biswal, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421146 · Cited by 991
Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M.-I., Kobayashi, A., Yamamoto, M., Kensler, T. W., & Talalay, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307301101 · Cited by 986 · cited 1×
“[43] Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, et al.”
BackgroundCullinan, S. B., Gordan, J. D., Jin, J., Harper, J. W., & Diehl, J. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8477-8486.2004 · Cited by 986
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Wang, X.-J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn095 · Cited by 839
Self-citationAn important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen
Chan, K., Han, X.-D., & Kan, Y. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081082098 · Cited by 770
Tong, K. I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2887-2900.2006 · Cited by 759 · cited 2×
“hat bind the Kelch domain of Keap1, which is the proposed hinge nd latch two-site binding model [54,55].”
BackgroundFurukawa, M., & Xiong, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.162-171.2005 · Cited by 746
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.-I., Kobayashi, A., Yokoyama, S., & Yamamoto, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.013 · Cited by 735 · cited 3×
“[30] Padmanabhan B, Tong KI, Ohta T, Nakamura Y, Scharlock M, Ohtsuji M, et al.”
BackgroundInfluentialEnomoto, A. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.1.169 · Cited by 728
Functional antioxidant responsive elements
Wasserman, W. W., & Fahl, W. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5361 · Cited by 705
Martin, D., Rojo, A. I., Salinas, M., Diaz, R., Gallardo, G., Alam, J., de Galarreta, C. M. R., & Cuadrado, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309660200 · Cited by 700
Role of NRF2 in Protection Against Hyperoxic Lung Injury in Mice
Cho, H.-Y., Jedlicka, A. E., Reddy, S. P. M., Kensler, T. W., Yamamoto, M., Zhang, L.-Y., & Kleeberger, S. R. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.2.4501 · Cited by 659
McMahon, M. J., Itoh, K., Yamamoto, M. P., Chanas, S. A., Henderson, C. J., McLellan, L. I., Wolf, C. R., Cavin, C., & Hayes, J. D. (2001) · PubMed · Cited by 651
Chan, K., Lu, R., Chang, J. C., & Kan, Y. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13943 · Cited by 645
Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
Ohta, T., Iijima, K., Miyamoto, M., Nakahara, I., Tanaka, H., Ohtsuji, M., Suzuki, T., Kobayashi, A., Yokota, J., Sakiyama, T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5003 · Cited by 629
Glutathione peroxidase family – an evolutionary overview
Margis, R., Dunand, C., Teixeira, F. K., & Margis‐Pinheiro, M. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06542.x · Cited by 610
Phytochemicals from Cruciferous Plants Protect against Cancer by Modulating Carcinogen Metabolism
Talalay, P., & Fahey, J. W. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3027s · Cited by 609
Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling
Lo, S., Li, X., Henzl, M. T., Beamer, L. J., & Hannink, M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601243 · Cited by 604 · cited 1×
“[29] Lo SC, Li X, Henzl MT, Beamer LJ, Hannink M.”
BackgroundThe thioredoxin system in cancer
Arnér, E. S. J., & Holmgren, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.10.009 · Cited by 589
Nrf2 is essential for protection against acute pulmonary injury in mice
Chan, K., & Kan, Y. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12731 · Cited by 574
Dinkova-Kostova, A. T., Liby, K. T., Stephenson, K. K., Holtzclaw, W. D., Gao, X., Suh, N., Williams, C., Risingsong, R., Honda, T., Gribble, G. W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500815102 · Cited by 569
LEVONEN, A.-L., LANDAR, A., RAMACHANDRAN, A., CEASER, E. K., DICKINSON, D. A., ZANONI, G., MORROW, J. D., & DARLEY-USMAR, V. M. (2004) · Biochemical Journal · doi:10.1042/bj20031049 · Cited by 560
Katoh, Y., Itoh, K., Yoshida, E., Miyagishi, M., Fukamizu, A., & Yamamoto, M. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00469.x · Cited by 520
Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity
Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J., Motohashi, H., & Yamamoto, M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01704-07 · Cited by 513
NIOI, P., McMAHON, M., ITOH, K., YAMAMOTO, M., & HAYES, J. D. (2003) · Biochemical Journal · doi:10.1042/bj20030754 · Cited by 507
Zaman, G. J., Lankelma, J., van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Oude Elferink, R. P., Baas, F., & Borst, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7690 · Cited by 498
Na, H.-K., & Surh, Y.-J. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.10.006 · Cited by 485
McMahon, M., Thomas, N., Itoh, K., Yamamoto, M., & Hayes, J. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601119200 · Cited by 485
Shapiro, T. A., Fahey, J. W., Wade, K. L., Stephenson, K. K., & Talalay, P. (2001) · PubMed · Cited by 476
Stewart, D., Killeen, E., Naquin, R., Alam, S., & Alam, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209195200 · Cited by 463
CHANAS, S. A., JIANG, Q., McMAHON, M., McWALTER, G. K., McLELLAN, L. I., ELCOMBE, C. R., HENDERSON, C. J., WOLF, C. R., MOFFAT, G. J., ITOH, K., et al. (2002) · Biochemical Journal · doi:10.1042/bj20020320 · Cited by 460
Eggler, A. L., Liu, G., Pezzuto, J. M., van Breemen, R. B., & Mesecar, A. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502402102 · Cited by 456
Kode, A., Rajendrasozhan, S., Caito, S., Yang, S.-R., Megson, I. L., & Rahman, I. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00361.2007 · Cited by 447
Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive Agents
Kelloff, G. J., Crowell, J. A., Steele, V. E., Lubet, R. A., Malone, W. A., Boone, C. W., Kopelovich, L., Hawk, E. T., Lieberman, R., Lawrence, J. A., et al. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.467s · Cited by 441
Sporn, M. B., & Suh, N. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.525 · Cited by 439
Chen, C.-Y., Jang, J.-H., Li, M.-H., & Surh, Y.-J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.237 · Cited by 428
Cafestol and Kahweol, Two Coffee Specific Diterpenes with Anticarcinogenic Activity
Cavin, C., Holzhaeuser, D., Scharf, G., Constable, A., Huber, W. W., & Schilter, B. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00029-7 · Cited by 422
Cope, G. A., & Deshaies, R. J. (2003) · Cell · doi:10.1016/s0092-8674(03)00722-0 · Cited by 409
Satoh, T., Kosaka, K., Itoh, K., Kobayashi, A., Yamamoto, M., Shimojo, Y., Kitajima, C., Cui, J., Kamins, J., Okamoto, S., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05039.x · Cited by 393
Heme Oxygenase-1 in Tumors: Is It a False Friend?
Jozkowicz, A., Was, H., & Dulak, J. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1659 · Cited by 382
The Carboxy-Terminal Neh3 Domain of Nrf2 Is Required for Transcriptional Activation
Nioi, P., Nguyen, T., Sherratt, P. J., & Pickett, C. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.10895-10906.2005 · Cited by 381
Iida, K., Itoh, K., Kumagai, Y., Oyasu, R., Hattori, K., Kawai, K., Shimazui, T., Akaza, H., & Yamamoto, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1906 · Cited by 370
Nrf2: A Potential Molecular Target for Cancer Chemoprevention by Natural Compounds
Jeong, W.-S., Jun, M., & Kong, A.-N. T. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.99 · Cited by 367
Nioi, P., & Hayes, J. D. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.05.023 · Cited by 362
Glutathione peroxidases and redox-regulated transcription factors
Brigelius-Flohé, R. (2006) · Biological Chemistry · doi:10.1515/bc.2006.166 · Cited by 360
The transcription factor NRF2 protects against pulmonary fibrosis
Cho, H.-Y., Reddy, S. P. M., Yamamoto, M., & Kleeberger, S. R. (2004) · The FASEB Journal · doi:10.1096/fj.03-1127fje · Cited by 355
Nguyen, T., Sherratt, P. J., Nioi, P., Yang, C. S., & Pickett, C. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503074200 · Cited by 344
The GI-GPx Gene Is a Target for Nrf2
Banning, A., Deubel, S., Kluth, D., Zhou, Z., & Brigelius-Flohé, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4914-4923.2005 · Cited by 344
Nrf2‐deficient mice are highly susceptible to cigarette smoke‐induced emphysema
Iizuka, T., Ishii, Y., Itoh, K., Kiwamoto, T., Kimura, T., Matsuno, Y., Morishima, Y., Hegab, A. E., Homma, S., Nomura, A., et al. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00905.x · Cited by 336
Sun, Z., Zhang, S., Chan, J. Y., & Zhang, D. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00630-07 · Cited by 332
Self-citationKwak, M.-K., Itoh, K., Yamamoto, M. P., Sutter, T. R., & Kensler, T. W. (2001) · PubMed Central · Cited by 330
Chan, J. Y., & Kwong, M. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00238-4 · Cited by 320
Hayes, J. D., Chanas, S. A., Henderson, C. J., McMahon, M., Sun, C., Moffat, G. J., Wolf, C. R., & Yamamoto, M. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280033 · Cited by 320
Carotenoids activate the antioxidant response element transcription system
Ben-Dor, A., Steiner, M., Gheber, L., Danilenko, M., Dubi, N., Linnewiel, K., Zick, A., Sharoni, Y., & Levy, J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.177.4.1 · Cited by 319
Perspectives on Cancer Chemoprevention Research and Drug Development
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)61026-x · Cited by 317
Specific Patterns of Electrophile Adduction Trigger Keap1 Ubiquitination and Nrf2 Activation
Hong, F., Sekhar, K. R., Freeman, M. L., & Liebler, D. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503346200 · Cited by 317
Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1
Asher, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.021558898 · Cited by 317
Hemin-induced Activation of the Thioredoxin Gene by Nrf2
Kim, Y.-C., Masutani, H., Yamaguchi, Y., Itoh, K., Yamamoto, M., & Yodoi, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100103200 · Cited by 314
Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues
Siegel, D., & Ross, D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00310-5 · Cited by 298
Zhang, D. D., Lo, S.-C., Sun, Z., Habib, G. M., Lieberman, M. W., & Hannink, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501279200 · Cited by 298
Self-citationAccelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust
Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K., & Yamamoto, M. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9176 · Cited by 297
Liby, K., Hock, T., Yore, M. M., Suh, N., Place, A. E., Risingsong, R., Williams, C. R., Royce, D. B., Honda, T., Honda, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4539 · Cited by 283
A Sulforaphane Analogue That Potently Activates the Nrf2-dependent Detoxification Pathway
Morimitsu, Y., Nakagawa, Y., Hayashi, K., Fujii, H., Kumagai, T., Nakamura, Y., Osawa, T., Horio, F., Itoh, K., Iida, K., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110244200 · Cited by 273
Yoo, M.-H., Xu, X.-M., Carlson, B. A., Gladyshev, V. N., & Hatfield, D. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600012200 · Cited by 270
Hayashi, A., Suzuki, H., Itoh, K., Yamamoto, M., & Sugiyama, Y. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.086 · Cited by 267
Schlager, J. J., & Powis, G. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450304 · Cited by 262
Chen, C., Pung, D., Leong, V., Hebbar, V., Shen, G., Nair, S., Li, W., & Tony Kong, A.-N. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.07.021 · Cited by 260
Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
Wang, R., An, J., Ji, F., Jiao, H., Sun, H., & Zhou, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.004 · Cited by 259
Kim, Y.-J., Ahn, J.-Y., Liang, P., Ip, C., Zhang, Y., & Park, Y.-M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2401 · Cited by 255
Maher, J. M., Cheng, X., Slitt, A. L., Dieter, M. Z., & Klaassen, C. D. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003798 · Cited by 255
Kweon, M.-H., Adhami, V. M., Lee, J.-S., & Mukhtar, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604748200 · Cited by 250
Crystal Structure of the Kelch Domain of Human Keap1
Li, X., Zhang, D., Hannink, M., & Beamer, L. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410073200 · Cited by 246
Self-citationMoinova, H. R., & Mulcahy, R. T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1109 · Cited by 245
Velichkova, M., & Hasson, T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4501-4513.2005 · Cited by 237
Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene
Vollrath, V., Wielandt, A. M., Iruretagoyena, M., & Chianale, J. (2006) · Biochemical Journal · doi:10.1042/bj20051518 · Cited by 225
A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
Nioi, P., & Nguyen, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.051 · Cited by 212
Sakurai, A., Nishimoto, M., Himeno, S., Imura, N., Tsujimoto, M., Kunimoto, M., & Hara, S. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20246 · Cited by 207
Overexpression of Heme Oxygenase-1 in Murine Melanoma
Was, H., Cichon, T., Smolarczyk, R., Rudnicka, D., Stopa, M., Chevalier, C., Leger, J. J., Lackowska, B., Grochot, A., Bojkowska, K., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051365 · Cited by 192
Sites of alkylation of human Keap1 by natural chemoprevention agents
Luo, Y., Eggler, A. L., Liu, D., Liu, G., Mesecar, A. D., & van Breemen, R. B. (2007) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2007.09.015 · Cited by 190
Garg, R., Gupta, S., & Maru, G. B. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn064 · Cited by 185
Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity
Nowis, D., Legat, M., Grzela, T., Niderla, J., Wilczek, E., Wilczynski, G. M., Głodkowska, E., Mrówka, P., Issat, T., Dulak, J., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209378 · Cited by 184
Ban, N., Takahashi, Y., Takayama, T., Kura, T., Katahira, T., Sakamaki, S., & Niitsu, Y. (1996) · PubMed · Cited by 183
Arsenic-induced malignant transformation of human keratinocytes: Involvement of Nrf2
Pi, J., Diwan, B. A., Sun, Y., Liu, J., Qu, W., He, Y., Styblo, M., & Waalkes, M. P. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.020 · Cited by 183
Doi, K., Akaike, T., Fujii, S., Tanaka, S., Ikebe, N., Beppu, T., Shibahara, S., Ogawa, M., & Maeda, H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690624 · Cited by 182
Zerumbone, a tropical ginger sesquiterpene, activates phase II drug metabolizing enzymes
Nakamura, Y., Yoshida, C., Murakami, A., Ohigashi, H., Osawa, T., & Uchida, K. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.042 · Cited by 180
Karapetian, R. N., Evstafieva, A. G., Abaeva, I. S., Chichkova, N. V., Filonov, G. S., Rubtsov, Y. P., Sukhacheva, E. A., Melnikov, S. V., Schneider, U., Wanker, E. E., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1089-1099.2005 · Cited by 173
Kim, S. K., Yang, J. W., Kim, M. R., Roh, S. H., Kim, H. G., Lee, K. Y., Jeong, H. G., & Kang, K. W. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.011 · Cited by 170
Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour
Tanaka, S., Akaike, T., Fang, J., Beppu, T., Ogawa, M., Tamura, F., Miyamoto, Y., & Maeda, H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600830 · Cited by 166
Cho, J.-M., Manandhar, S., Lee, H.-R., Park, H.-M., & Kwak, M.-K. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.10.022 · Cited by 166
Nrf2-Keap1 Signaling Pathway Regulates Human UGT1A1 Expression in Vitro and in Transgenic UGT1 Mice
Yueh, M., & Tukey, R. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610790200 · Cited by 163
Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2
Aleksunes, L. M., Slitt, A. L., Maher, J. M., Augustine, L. M., Goedken, M. J., Chan, J. Y., Cherrington, N. J., Klaassen, C. D., & Manautou, J. E. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.08.022 · Cited by 162
Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer
Chu, F., Esworthy, R. S., & Doroshow, J. H. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.010 · Cited by 160
Shen, G., Xu, C., Hu, R., Jain, M. R., Nair, S., Lin, W., Yang, C. S., Chan, J. Y., & Kong, A.-N. T. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7546-8 · Cited by 159
Liao, B., Hsieh, C., Liu, Y., Tzeng, T.-T., Sun, Y.-W., & Wung, B. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.01.021 · Cited by 155
Zhu, M., & Fahl, W. E. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5944 · Cited by 148
Kelly, V. P., Ellis, E. M., Manson, M. M., Chanas, S. A., Moffat, G. J., McLeod, R., Judah, D. J., Neal, G. E., & Hayes, J. D. (2000) · PubMed · Cited by 147
Higgins, L. G., Cavin, C., Itoh, K., Yamamoto, M. P., & Hayes, J. D. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.09.018 · Cited by 145
The role of glutathione-dependent enzymes in drug resistance
Black, S. M., & Wolf, C. R. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90044-m · Cited by 143
Selenium Compounds and Selenoproteins in Cancer
Brigelius‐Flohé, R. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890039 · Cited by 137
Wang, X.-J., Sun, Z., Chen, W., Li, Y., Villeneuve, N. F., & Zhang, D. D. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.003 · Cited by 137
Self-citationIKEDA, H., NISHI, S., & SAKAI, M. (2004) · Biochemical Journal · doi:10.1042/bj20031948 · Cited by 136
HO-1 underlies resistance of AML cells to TNF-induced apoptosis
Rushworth, S. A., & MacEwan, D. J. (2008) · Blood · doi:10.1182/blood-2007-07-104042 · Cited by 135
Meijerman, I., Beijnen, J. H., & Schellens, J. H. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.03.002 · Cited by 132
Chemoprotection by Organosulfur Inducers of Phase 2 Enzymes: Dithiolethiones and Dithiins
Kensler, T. W., Curphey, T. J., Maxiutenko, Y., & Roebuck, B. D. (2000) · Drug metabolism and drug interactions · doi:10.1515/dmdi.2000.17.1-4.3 · Cited by 131
Hintze, K. J., Wald, K., Zeng, H., Jeffery, E. H., & Finley, J. W. (2003) · Journal of Nutrition · doi:10.1093/jn/133.9.2721 · Cited by 129
Sasada, T., Nakamura, H., Ueda, S., Sato, N., Kitaoka, Y., Gon, Y., Takabayashi, A., Spyrou, G., Holmgren, A., & Yodoi, J. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00101-x · Cited by 126
Diallyl sulfide induces heme oxygenase-1 through MAPK pathway
Gong, P., Hu, B., & Cederbaum, A. I. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.024 · Cited by 125
Peroxiredoxin I expression in human thyroid tumors
Yanagawa, T., Ishikawa, T., Ishii, T., Tabuchi, K., Iwasa, S., Bannai, S., Omura, K., Suzuki, H., & Yoshida, H. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00243-8 · Cited by 124
Kim, H.-R., Kim, S.-J., Kim, E., Park, J., Yang, S., Jeong, E., Park, C., Youn, M., So, H., & Park, R. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.09.021 · Cited by 114
Sekhar, K. R., Crooks, P. A., Sonar, V. N., Friedman, D. B., Chan, J. Y., Meredith, M. J., Starnes, J. H., Kelton, K. R., Summar, S. R., Sasi, S., et al. (2003) · PubMed · Cited by 105
Du, Y., Villeneuve, N. F., Wang, X., Sun, Z., Chen, W., Li, J., Lou, H., Wong, P. K., & Zhang, D. D. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11464 · Cited by 101
Self-citationTarumoto, T., Nagai, T., Ohmine, K., Miyoshi, T., Nakamura, M., Kondo, T., Mitsugi, K., Nakano, S., Muroi, K., Komatsu, N., et al. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.01.007 · Cited by 97
Schisselbauer, J. C., SILBER, R. H., Papadopoulos, E. B., Abrams, K. L., LaCreta, F. P., & Tew, K. D. (1990) · PubMed · Cited by 94
Umemura, T., Kuroiwa, Y., Kitamura, Y., Ishii, Y., Kanki, K., Kodama, Y., Itoh, K., Yamamoto, M. P., Nishikawa, A., & Hirose, M. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfj076 · Cited by 81
Eggler, A. L., Luo, Y., van Breemen, R. B., & Mesecar, A. D. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700217c · Cited by 80
Kim, J.-H., Bogner, P. N., Ramnath, N., Park, Y., Yu, J., & Park, Y. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2893 · Cited by 80
Lee, H., Cho, J., Shin, D., Yong, C. S., Choi, H.-G., Wakabayashi, N., & Kwak, M. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9853-y · Cited by 79
Piperine protects cisplatin-induced apoptosis via heme oxygenase-1 induction in auditory cells
Choi, B., Kim, S., Park, T.-K., Li, G., Hong, S.-J., Park, R., Chung, H., & Kim, B.-R. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.11.012 · Cited by 79
Kim, H., So, H., Lee, J., Lee, J., Park, C., Park, S.-Y., Kim, Y., Youn, M., Kim, S.-J., Chung, S.-Y., et al. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.018 · Cited by 75
Akan, I., Akan, S., Akça, H., Savaş, B., & Özben, T. (2005) · Cancer Cell International · doi:10.1186/1475-2867-5-22 · Cited by 73
Chemoprevention: Increased potential to bear fruit
Wolf, C. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071042698 · Cited by 63
Vanhoefer, U. J., Cao, S., Minderman, H., Tóth, K., Skenderis, B. S., Slovak, M. L., & Rustum, Y. M. (1996) · PubMed · Cited by 59
Campbell, L., Howie, F. A., Arthur, J. R., Nicol, F., & Beckett, G. J. (2006) · Nutrition · doi:10.1016/j.nut.2006.10.006 · Cited by 59
Ishii, T., & Yanagawa, T. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-6051-9_18 · Cited by 57
Mikami, K., Naito, M., Ishiguro, T., Yano, H., Tomida, A., Takeshi, Y., Tanaka, N., Shirakusa, T., & Tsuruo, T. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00648.x · Cited by 54
Expression pattern of gastrointestinal selenoproteins— targets for selenium supplementation
Mörk, H., Lex, B., Scheurlen, M., Dreher, I., Schütze, N., Köhrle, J., & Jakob, F. J. (1998) · Nutrition and Cancer · doi:10.1080/01635589809514720 · Cited by 49
Haridas, V., Kim, S.-O., Nishimura, G., Hausladen, A., Stamler, J. S., & Gutterman, J. U. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504430102 · Cited by 44
Janus face of Nrf2–HO-1 axis in cancer—Friend in chemoprevention, foe in anticancer therapy
Łoboda, A., Waś, H., Józkowicz, A., & Dulak, J. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.10.024 · Cited by 34
Li, J., & Johnson, J. A. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00003.2002 · Cited by 29
Basu, S., Brown, J. E., Flannigan, G. M., Gill, J. H., Loadman, P. M., Martin, S. W., Naylor, B., Scally, A., Seargent, J. M., Shah, T. K., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20005 · Cited by 27
Chuman, Y., Chen, Z., Seto, K., Sumizawa, T., Furukawa, T., Tani, A., Haraguchi, M., Niwa, K., Yamada, K., Aikou, T., et al. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00083-4 · Cited by 26
Padmanabhan, B., Scharlock, M., Tong, K. I., Nakamura, Y., Kang, M.-I., Kobayashi, A., Matsumoto, T., Tanaka, A., Yamamoto, M., & Yokoyama, S. (2004) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309104032506 · Cited by 16
Cited by
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Brigelius-Flohé, R., & Maiorino, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.020 · Cited by 1,904
The emerging role of the Nrf2–Keap1 signaling pathway in cancer
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,297
Self-citationThe development of the concept of ferroptosis
Hirschhorn, T., & Stockwell, B. R. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.043 · Cited by 1,052
Metadata
- Authors
- LAU, A., VILLENEUVE, N., SUN, Z., WONG, P., & ZHANG, D.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 58
- Issue
- 5-6
- Pages
- 262-270
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2059378857
- Cited by
- 645
- References
- 152
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.